To reduce Australia's future dementia burden, it is imperative to develop methods to identify those Australians at the very early stage of dementia. To achieve this goal, we are establishing multidisciplinary research projects to track disease progression from the very early stage. These projects use cutting-edge neuroscience technologies to examine how the mind and brain change in dementia. My goal is to discover novel methods for early detection, and develop early intervention strategies.
Multidisciplinary Translational Research To Address Social Disparities In Osteoporosis: Understanding The Social Context Of Biological Mechanisms
Funder
National Health and Medical Research Council
Funding Amount
$419,180.00
Summary
Osteoporosis (OP) prevalence is greater for disadvantaged groups, as are less healthy lifestyles. Whilst reasons for this social gradient of OP are unknown, some biological phenomena are influenced by lifestyle factors. I will provide novel evidence about biological mechanisms underlying the social gradient of OP (epigenetics), and, using that information, engage disadvantaged communities in multidisciplinary discussions to inform effective public health interventions (community engagement).
A Program Of Methodological And Collaborative Research In Biostatistics And Population Health
Funder
National Health and Medical Research Council
Funding Amount
$264,081.00
Summary
Biostatistics is a critical component of health and medical research, especially for studies in population health. However, there is an increasing gap between supply and demand for high-level biostatistical input. This proposal combines novel methodological research into methods for analysing incomplete data, with collaborative research applying new ideas and complex analyses to important health problems. The fellowship will facilitate my development as a future leader in this key area.
Short Term Effects Of Overfeeding On Metabolic Risk In Humans
Funder
National Health and Medical Research Council
Funding Amount
$380,558.00
Summary
Obesity is associated with increased risk of diabetes, heart disease and cancer. Obesity prevalence is rapidly increasing and consitutes one of the greatest threats to human health. The aim of this study is to determine mechanism-s underlying the close relationship between obesity and insulin resistance by inducing experimental weight gain in humans with and without a genetic predisposition to diabetes. This project will help identify new candidates for anti-diabetes drugs.
Mitochondrial Energy Metabolism And Insulin Action
Funder
National Health and Medical Research Council
Funding Amount
$380,558.00
Summary
Obesity and type 2 diabetes are two major health conditions associated with abnormal energy metabolism. In this proposal I will investigate the role of important metabolic proteins in regulating energy expenditure and insulin action in skeletal muscle and adipose tissue, two crucial tissues for whole-body energy metabolism. These studies will provide critical insight into the factors leading to obesity and type 2 diabetes and will assist in identifying possible therapeutic targets.
Elucidating The Molecular Regulation Of Gp130 Complex Signalling In Lipid And Glucose Metabolism.
Funder
National Health and Medical Research Council
Funding Amount
$387,489.00
Summary
Overnutrition promotes obesity, which greatly increases the risk of type 2 diabetes and cardiovascular disease. We have provided evidence that activation of gp130 signalling may enhance insulin action and fatty acid oxidation in metabolically active tissues. My research proposal aims to elucidate the molecular regulation of gp130 complex signalling in lipid and glucose metabolism in important metabolic tissues.
Investigating Mitochondrial Outer Membrane Permeabilization During Programmed Cell Death
Funder
National Health and Medical Research Council
Funding Amount
$88,065.00
Summary
Cancer cells often contain defects which prevent their death. To kill cancer cells we must either reset or bypass these defects. Release of cytochrome c from mitochondria is a critical event in cell death and proteins that block this event render cells resistant to many cancer therapies. My research will determine how cytochrome c release occurs, how this event is regulated and how to kill cancer cells in which cytochrome c release is blocked.